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Abstract
Tight glucose control during the acute care of patients with severe traumatic brain injury has recently
been advocated based on experimental concerns about deleterious effects of presenting the injured
brain with a high glucose load, however, there is little or no clinical evidence that hyperglycemia
worsens neurologic injury. The majority of the clinical studies of tight glucose control find that it is
associated with an increased risk of hypoglycemic episodes and cellular injury, when compared to
conventional glucose control protocols.
Introduction and context
Traumatic brain injury (TBI) causes cerebral ischemia
and disrupts normal cerebral metabolism. Anaerobic
conditions result in post-traumatic changes in glucose
metabolism that can have long-term consequences. For
example, in chronic TBI studies, 6 months after patients
suffered diffuse axonal injury, fluorodeoxyglucose posi-
tron emission tomography (PET) analysis shows bilat-
eral regional decreases of resting glucose metabolism in
the frontal and temporal lobes, thalamus, and cerebel-
lum, compared with healthy gender-matched controls
[1]. In patients with persistent neuropsychological
deficits, these glucose hypometabolic areas are especially
prominent in the cingulate gyrus [2].
Early after TBI, elevated serum glucose levels have been
considered deleterious based on the assumption that
presentation of the ischemic brain with high levels of
glucose would drive anaerobic glycolysis, resulting in the
accumulation of toxic levels of lactic acid. At least one
study found that persistent hyperglycemia, defined as
average daily blood glucose levels >149 mg/dl for the
first week after injury, was associated with a five-fold
increase in mortality in a cohort of 834 patients with
severe TBI [3]. Others have found that maintenance of
blood glucose below 145 mg/dl significantly reduces
lactate production, and results in optimal lactate/glucose
and oxygen/glucose indices (as determined from arterial-
jugular venous lactate, and glucose and oxygen content
differences) following severe TBI, at least as compared to
higher blood glucose levels [4].
The mechanisms whereby glucose may worsen the
ischemic threshold in neurons after injury are not well
understood. In neuron cultures exposed to ischemic
conditions, post-ischemic superoxide production and
cell death are prevented by removing glucose from the
medium [5]. These studies suggest that glucose is a
requisite electrondonor for reperfusion-inducedneuronal
superoxide production. Moreover, investigations of the
mechanisms of neuronal injury that result from hypogly-
cemic coma have led some to conclude that the injury
from hypoglycemia actually occurs with reperfusion,
where high blood glucose concentrations initiate neuro-
nal death by a mechanism involving extracellular zinc
release and activation of neuronal NADPH oxidase [6].
Because of the depression of aerobic metabolism follow-
ing TBI, and associated mitochondrial dysfunction,
elevation of brain tissue O2 tension has been shown to
significantly reduce extracellular lactate concentrations
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and experimental evidence that hyperglycemia lowers the
ischemic neuronal threshold in the presence of neurolo-
gical injury, and thatlactic acidosis increases astrocytic cell
death [8-10]. However, large clinical trials of therapies
designed to induce a metabolic alkalosis [tromethamine
(THAM)] or respiratory alkalosis (hyperventilation),
based on the concern about post-traumatic lactic acidosis,
did not find outcomes to be improved with these
therapies [11,12]. In fact, there was some evidence that




Based on the concern that even slightly elevated blood
glucose levels can cause or exacerbate secondary brain
injury, investigators have conducted clinical trials to test
the efficacy of ‘tight glucose control’, or maintenance of
blood glucose levels of less than 110-120 mg/dl by using
continuous insulin infusions. In a prospective study of
240 adult patients with severe TBI, patients were
randomly assigned either to a tight glucose control
group (intensive insulin therapy) with glucose levels
maintained at 80 mg/dl throughout their intensive care
unit (ICU) stay, or to a conventional glucose control
group where insulin was not given unless serum glucose
levels exceeded 200 mg/dl [13]. The groups were well
matched according to several measures of severity of
injury and age. Six-month mortality rates were similar for
the two groups, though significantly more patients in the
intensive insulin therapy group had good outcomes (that
is, a Glasgow Outcome Scale (GOS) score of 4 or 5) than
did the conventional therapy patients (29.1% versus
22.4%, P < 0.05). In addition, intensive insulin therapy
was associated with a significantly lower infection rate
and shorter ICU stay. However, the incidence of severe
hypoglycemia in the tight glucose control group was not
reported.
Most of the other clinical studies of patients with TBI, as
well as stroke and subarachnoid hemorrhage, have not
found benefit from tight glucose control, and there is
increasing concern about the associated risk of hypogly-
cemic episodes and the further neuronal injury that can
result from hypoglycemia [10,14,15]. Episodes of hypo-
glycemiahavebeenfoundtobeassociatedwithincreased
extracellular levels of glutamate, glycerol, and the lactate/
pyruvate ratio, all measures of cellular distress [16]. In
one prospective observational study of 30 ICU patients
(TBI, stroke, subarachnoid hemorrhage), the safety of
continuous insulin infusions for maintaining blood
glucose levels between 81 and 110 mg/dl was studied
[17]. Adherence to the protocol was 71%, but blood
glucose levels were maintained in the desired range for
only 42% of the total protocol implementation time.
Consequently, 60% of the patients in this study
experienced at least one hypoglycemic event. A retro-
spective comparison of 57 neuro-ICU patients who had
tight glucose control with 64 patients admitted to the
ICUprior toinitiationoftheprotocolalsofound ahigher
incidence of hypoglycemia, as well as a longer ICU stay,
inthegroupwithtightglucosecontrol[18].Aprospective
study of 97 patients with severe TBI assigned either to a
group targeted to blood glucose levels of 80-120 mg/dl
using a continuous insulin infusion, or to a group that
received insulin only if the blood glucose levels exceeded
220 mg/dl, also found that episodes of hypoglycemia,
defined as a blood glucose <80 mg/dl, were significantly
more common for the tight glucose control group [19].
Although the duration of ICU stay also was shorter for
that group, there was no difference in ICU infection rates,
or in GOS or mortality at 6 months.
Several investigators used microdialysis to examine the
metabolic effects of tight glucose control, with the probes
placed either in normal appearing brain, or brain
adjacent to contusions. Changes in dialysate levels of
glucose, lactate, and pyruvate have been shown to
correlate well with glucose metabolism as defined with
fluorodeoxyglucose-PET [20]. In 20 patients with severe
TBI, continuous insulin infusions were used to maintain
blood glucose levels of 80-120 mg/dl [21]. Patients with
dialysate glucose levels <0.7 mmol/L (12.6 mg/dl) and
lactate/pyruvate ratios >40 were considered in ‘brain
energy crisis’, and this condition was associated with a
seven-fold increase in the odds of mortality at hospital
discharge. Compared with patients in whom the blood
glucose was not tightly controlled (121-180 mg/dl), tight
glucose control was associated with a significant increase
in the incidence of dialysate glucose levels <0.7 mmol/L
(12.6 mg/dl) and lactate/pyruvate ratios >40 (brain
energy crisis). In similar studies at the University of
California, Los Angeles, 14 TBI patients acutely managed
with intensive insulin therapy were compared with
33 TBI patients treated with a ‘loose insulin protocol’
[22]. Intensive insulin therapy resulted in a 70%
reductionofdialysateglucoselevels,asignificantincrease
in the lactate/pyruvate ratio, which frequently exceeded
40, and increased levels of glutamate, another marker of
cellular distress following trauma. Significantly, more of
the intensive-insulin-therapy patients had critically low
extracellularglucoselevelscomparedwiththosewhohad
the loose insulin protocol. Moreover, the percentage of
time that the dialysate lactate/pyruvate ratio was above
40 was significantly correlated with the extent of frontal
lobe brain atrophy at 6 months after injury [23]. This was
observedeveninpatientswhohadhadnormalappearing
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scans immediately after injury.
During the acute care of patients with severe TBI, there is
some evidence that the optimal blood glucose level may
change over time. Meier et al. [24] retrospectively
evaluated the influence of predefined blood glucose
targets (63-117 mg/dl versus 90-144 mg/dl) on intracra-
nial pressure, mortality, and length of stay in the ICU in
228 patients with severe TBI. They found that maintain-
ing the blood glucose at 90-144 mg/dl was beneficial
during the first week after injury primarily because there
were significantly fewer hypoglycemic episodes in that
group compared to the group for whom 63-117 mg/dl
was the target. During the second week the group
maintained at the lower target range had a reduced
intracranial pressure, and decreased rates of pneumonia,
bacteremia, and urinary tract infections compared to the
higher blood glucose group.
Alternative fuels
Glucose may not be the optimum fuel for the acutely
injured brain. While glucose appears to be the primary
metabolic substrate in the healthy brain, lactate may be
the preferred energy substrate following TBI. In a rodent
study of cerebral oxygen consumption following fluid
percussion injury, it was found that glucose sustained
mitochondrial respiration at a low level ‘fixed’ rate, but
increasing its concentration did not result in up-
regulationof oxygen consumption [25]. However,lactate
administration resulted in a dose-dependent increase in
mitochondrial oxygen consumption that may well have
enabled the mitochondria to meet the increased energy
needs of the injured brain. There also is experimental
evidence that astrocytes contain low levels of glycogen,
and that during hypoglycemia the astrocyte glycogen
breaks down to lactate that is then transferred to adjacent
neurons or axons and is used aerobically as fuel [26].
Astrocyte glycogen is thereby thought to offer some
protection against hypoglycemic neural injury. Ketones
also have been proposed as an alternative fuel following
TBI [27]. In a murine study of controlled cortical impact
injury, feeding the rat a ketogenic diet after injury led to a
more rapid normalization of the cerebral metabolic rate
for glucose (CMRglucose), and decreased contusion
volume [28].
Implications for clinical practice
While there is experimental evidence that elevated blood
glucose levels can cause or exacerbate secondary brain
injury, a critical issue yet to be resolved is that of cause or
effect. In one large cohort of severely injured trauma
patients, those with early hyperglycemia did have a two-
fold higher mortality rate and a 30% higher incidence of
multiple organ failure compared to those who did not
[29]. Van Beek et al. [30] correlated admission glucose
levels to 6-month outcomes in nearly 5,000 patients
from six phase III trials entered into the IMPACT
(International Mission for Prognosis and Analysis of
Clinical Trials in TBI) database, and found a significant
association with increasing levels of admission blood
glucose and poor outcomes. But in both of these studies,
the increased blood glucose levels may have been related
to the increased stress response associated with more
severe injuries [31]; that is, elevated blood glucose levels
were a reflection, but not the cause, of very severe injury.
So while it is clear that with TBI, as well as with stroke
and a number of other neurologic diseases, hyperglyce-
mia is common soon after the injury, it is not clear that
aggressive reduction of the elevated blood glucose will
improve neurologic outcomes.
It is increasingly apparent, however, that tight glucose
control is not only associated with increased hypogly-
cemic episodes, but also with direct extracellular
(microdialysis) evidence of cellular distress and brain
energy crisis. In addition, there is evidence that lactate,
the principle metabolite of anaerobic glycolysis, may be
a preferred fuel for neurons after TBI. There even is
evidence for an increase in brain metabolic demand early
after injury that may lead to a deficiency in cerebral
extracellular glucose [32].
In conclusion, the majority of currently available clinical
and preclinical evidence does not support tight glucose
control (maintenance of blood glucose levels below 110-
120 mg/dl) during the acute care of patients with severe
TBI.
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